🏆 2026 National/Community Chronic Disease Subsidy Program | Limited-Time 70% OFF

Margaret, 67, lives in a small town in Texas. She has health insurance, but her monthly out-of-pocket costs still leave her breathless. What she fears most every month isn't pricking her finger—it's opening her medicine cabinet and watching the box of glucose test strips dwindle one by one.

To save test strips, she began living by “feeling.”
Dizzy? Maybe her blood sugar was low—she’d eat some candy.
Dry mouth? Maybe it was high—she’d drink more water.

Until one day, while standing in line at a grocery store, she suddenly collapsed. An ambulance rushed her to the emergency room.

ER Bill: $2,800. Diagnosis: Severe hypoglycemic coma.

The doctor asked her, “How often do you check your blood sugar?”

She lowered her head. “…Only when I feel unwell.”

The doctor fell silent. He had seen too many patients like her—not unwilling to test, but simply unable to afford it.

The turning point came in the third week after her discharge.

A staff member at the local community health center told her about a new chronic disease accessibility program—designed specifically for Medicare patients like her, offering affordable glucose monitoring solutions.

Margaret accepted the new glucometer with hesitation.

It was small, simple to use. The screen displayed large, clear numbers, and it even had voice prompts—she no longer needed to reach for her reading glasses.

The first time she used it, she stared at the number on the screen:

112 mg/dL.

“Normal,” she murmured.

Her eyes suddenly filled with tears.

Not because the number was perfect—
but because, for the first time, she no longer had to guess.

Three months later, Margaret had become the enthusiastic “glucometer ambassador” of her community.

“You know what?” she would tell everyone,
“Since I started monitoring regularly, my doctor has adjusted my medication twice. My HbA1c dropped from 8.9 to 7.1. This year, I’m even planning to fly to attend my granddaughter’s graduation.”

She smiled, gently patting the small device in her hand.

“This little thing… costs a lot less than my ER bill.”

Policy Context: What is the “Chronic Disease Accessibility Program”?

"Margaret is not an isolated case."

By 2026, more than 3.4 million chronic disease patients across the United States have gained access to affordable monitoring devices and health management services through the National/Community Chronic Disease Accessibility Program.

This initiative integrates multiple federal and state-level resources:

1.The Urban and Rural Diabetes Initiative Act (HR 6241):
Allocates $5 billion from 2026 to 2031, with a focus on diabetes prevention and management in medically underserved areas.

2.The CMS ACCESS Model:
Officially launching in July 2026, this program encourages healthcare providers to adopt remote monitoring and outcome-based payment models, allowing patients to receive professional-grade care from home.

3.The Medicare C-SNP Program:
Provides monthly OTC (over-the-counter) health product subsidies for chronic disease patients, enabling glucometers and test strips to be reimbursed directly.

In short:
Eligible U.S. residents can access unlimited multi-parameter health monitoring for less than the cost of a cup of Starbucks per month.

However, while policy has addressed the issue of cost, it has not yet solved the problems of pain and complexity—until a medical innovator introduced a true breakthrough.

(Doctor’s Breakthrough: From “Needles” to the 12-in-1 Non-Invasive Revolution)

“I couldn’t bear to see patients’ fingertips covered in scars anymore.”

These are the words of Dr. James Heller, former Professor of Biomedical Engineering at Johns Hopkins University, with 32 years of experience in wearable sensor development.

Dr. Heller’s father was also a diabetic patient.
Due to the need for daily finger-prick testing, his fingertips became covered with calluses and scars. In his later years, he even refused to continue monitoring—and ultimately passed away from diabetic ketoacidosis.

“That was the moment I made a promise:
to create a device that requires no needles, no blood, and can measure all core indicators in a single machine.”

After 7 years of research and development and three generations of clinical prototypes, Dr. Heller’s team finally achieved a breakthrough in the integration of:

Multi-spectral Dynamic Analysis + Bio-impedance Spectroscopy + High-sensitivity Electrochemical Sensors

The result is:

【12-in-1 Smart Glucometer】 — The World’s First Non-Invasive Multi-Functional Monitoring Device

In just 5 seconds, by simply placing your finger gently on the sensor area, the device simultaneously measures:

Margaret switched to the 12in1 device and says: “Now I measure glucose, blood pressure, and heart rate in 5 seconds, no pain, no strips. My doctor sees my trends remotely. I finally feel like a person, not a patient.”